WO2024240923 - PREBIOTICS FOR TREATING AND/OR PREVENTING VITAMIN K2 DEFICIENCY
National phase entry:
Publication Number
WO/2024/240923
Publication Date
28.11.2024
International Application No.
PCT/EP2024/064337
International Filing Date
24.05.2024
Title **
[English]
PREBIOTICS FOR TREATING AND/OR PREVENTING VITAMIN K2 DEFICIENCY
[French]
PRÉBIOTIQUES POUR LE TRAITEMENT ET/OU LA PRÉVENTION D'UNE DÉFICIENCE EN VITAMINE K2
Applicants **
SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Inventors
BOULANGE, Claire Laurence Lucie Marie
DUBOUX, Stéphane
CAMPOS GIMENEZ, Esther
HORCAJADA, Marie Noëlle
BONNET, Nicolas
Priority Data
23175289.0
25.05.2023
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2334 | |
| EPO | Filing, Examination, Granting | 10893 | |
| Japan | Filing, Examination, Granting | 2340 | |
| South Korea | Filing, Examination, Granting | 2405 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
22,712
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to a prebiotic agent for use in treating and/or preventing vitamin K2 deficiency in a subject. The present invention relates to the use of a prebiotic agent to promote vitamin K2 production in the gut of a subject.[French]
La présente invention concerne un agent prébiotique destiné à être utilisé dans le traitement et/ou la prévention d'une déficience en vitamine K2 chez un sujet. La présente invention concerne l'utilisation d'un agent prébiotique pour favoriser la production de vitamine K2 dans l'intestin d'un sujet.